Literature DB >> 25914073

Opportunistic salpingectomies for the prevention of a high-grade serous carcinoma: a statement by the Kommission Ovar of the AGO.

Martin Pölcher1, Steffen Hauptmann, Christina Fotopoulou, Barbara Schmalfeldt, Ivo Meinhold-Heerlein, Alexander Mustea, Ingo Runnebaum, Jalid Sehouli.   

Abstract

The detection of premalignant cells in the epithelium of the fallopian tube has resulted in revolutionary theories regarding the origin of epithelial ovarian cancer (EOC). Serous tubal intra-epithelial carcinomas (STIC) have been detected in patients with BRCA 1 or 2 mutations and are considered as the most likely precursors of the high-grade serous ovarian cancer (HGSOC), which is the most common histological subtype in patients with EOC. A bilateral salpingo-oophorectomy is associated with a significant reduction in risk of developing EOC. According to various national guidelines, prophylactic bilateral salpingo-oophorectomy should be performed in the age group 40-45 years. As in patients with BRCA mutations, the prophylactic removal of the fallopian tubes is also performed in women without an increased genetic risk, for example, in surgical treatments of benign conditions. There is a current debate as to whether prophylactic or so-called opportunistic salpingectomy will influence the overall incidence of EOC in the coming years. Opponents of this theory warn of a higher surgical morbidity and the higher risk of a premature menopause through impaired vascular supply to the ovaries. The value of opportunistic salpingectomies has not yet been clarified since there are currently no systematic risk-benefit evaluations. This review will attempt to give an overview of the current body of evidence regarding the risks and benefits of opportunistic salpingectomies.

Entities:  

Mesh:

Year:  2015        PMID: 25914073     DOI: 10.1007/s00404-015-3697-y

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  12 in total

1.  Should Fallopian Tubes Be Removed During Hysterectomy Procedures? - A Statement by AGO Ovar.

Authors:  M Pölcher; S Hauptmann; C Fotopoulou; B Schmalfeldt; I Meinhold-Heerlein; A Mustea; I Runnebaum; J Sehouli
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-04       Impact factor: 2.915

2.  Incidental (Prophylactic) Salpingectomy at Benign Gynecologic Surgery and Cesarean Section: a Survey of Practice in Austria.

Authors:  F L Potz; G Tomasch; S Polterauer; R Laky; C Marth; K Tamussino
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-12       Impact factor: 2.915

3.  Primary peritoneal cancer in BRCA carriers after prophylactic bilateral salpingo-oophorectomy.

Authors:  Christos Iavazzo; Ioannis D Gkegkes; Nikolaos Vrachnis
Journal:  J Turk Ger Gynecol Assoc       Date:  2016-01-12

4.  Risk reduction surgery (RRS) for tubo-ovarian cancer in an Irish gynaecological practice: an analysis of indications and outcomes.

Authors:  Claire Thompson; Ciara McCormick; Waseem Kamran; Ciaran O'Riain; Lucy Norris; David Gallagher; Noreen Gleeson
Journal:  Ir J Med Sci       Date:  2018-01-03       Impact factor: 1.568

Review 5.  Luteinising hormone releasing hormone (LHRH) agonists for the treatment of relapsed epithelial ovarian cancer.

Authors:  Rekha Wuntakal; Srividya Seshadri; Ana Montes; Geoff Lane
Journal:  Cochrane Database Syst Rev       Date:  2016-06-29

6.  Opportunistic salpingectomy at benign gynecological surgery for reducing ovarian cancer risk: a 10-year single centre experience from China and a literature review.

Authors:  Ying Chen; Hui Du; Lewen Bao; Wenxin Liu
Journal:  J Cancer       Date:  2018-01-01       Impact factor: 4.207

7.  Prophylactic salpingectomy and ovarian cancer: An evidence-based analysis.

Authors:  Tricia Dewi Anggraeni; Adly Nanda Al Fattah; Raymond Surya
Journal:  South Asian J Cancer       Date:  2018 Jan-Mar

8.  Review article: Novel technologies in the treatment and monitoring of advanced and relapsed epithelial ovarian cancer.

Authors:  Paula Cunnea; Sally Gowers; James E Moore; Emmanuel Drakakis; Martyn Boutelle; Christina Fotopoulou
Journal:  Converg Sci Phys Oncol       Date:  2017-02-23

Review 9.  Bilateral salpingectomy to reduce the risk of ovarian/fallopian/peritoneal cancer in women at average risk: a position statement of the Korean Society of Obstetrics and Gynecology (KSOG).

Authors:  Miseon Kim; Young-Han Kim; Yong Beom Kim; Jayeon Kim; Jae-Weon Kim; Mi Hye Park; Joo Hyun Park; Jeong Ho Rhee; Myong Cheol Lim; Joon-Seok Hong
Journal:  Obstet Gynecol Sci       Date:  2018-09-07

10.  Opportunistic Salpingectomy at the Time of Benign Laparoscopic Hysterectomy: Assessment of Possible Complications and Histopathological p53-Signatures.

Authors:  Gautier Chene; Sarah Urvoas; Stéphanie Moret; Béatrice Nadaud; Annie Buenerd; Philippe Chabert; Georges Mellier; Gery Lamblin
Journal:  Geburtshilfe Frauenheilkd       Date:  2018-06-25       Impact factor: 2.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.